Snellingen T, Evans J R, Ravilla T, Foster A
Institute of Clinical Medicine, University of Tromso, ISM UiTo, Tromso, Troms, Norway, 9037.
Cochrane Database Syst Rev. 2002(2):CD001323. doi: 10.1002/14651858.CD001323.
Cataract is the major cause of global blindness, accounting for 40 to 80% of all blindness in developing countries. The number of people blind from cataract is expected to rise due to the changing age distribution and increasing life expectancy. There is currently no proven intervention to prevent cataract and surgery is the only form of treatment.
The objective of this review is to compare the effects of different surgical interventions for age-related cataract.
We searched the Cochrane Controlled Trials Register - CENTRAL/CCTR, which contains the Cochrane Eyes and Vision Group specialised register (Cochrane Library Issue 3 2001), MEDLINE (1966 to August 2001), EMBASE (1980 to September 2001), the reference lists of identified trials, and we contacted investigators and experts in the field for details of published and unpublished trials.
We included randomised controlled trials evaluating surgical treatment for people with age-related cataract.
Two reviewers independently extracted data and discrepancies were resolved by discussion. Where appropriate, relative risks, odds ratios and weighted mean differences were summarised after assessing heterogeneity between the studies. We used a fixed effect model due to the low number of trials in each comparison.
We identified six trials that randomised a total of 7828 people. Phacoemulsification gave a better visual outcome than extracapsular surgery and gave a similar average cost per procedure in one trial conducted in the UK. Extracapsular surgery with posterior chamber lens implant and intracapsular surgery with or without an anterior chamber intraocular lens implant gave acceptable visual outcomes at 12 to 24 months after surgery. In three large trials in south Asia, best-corrected visual acuity of less than 6/60 ranged from 0.5 to 4%. Higher rates of poor outcome were observed in a multicentre study with 19 surgeons compared to a single-centre study with two surgeons.
REVIEWER'S CONCLUSIONS: This review provides evidence from one randomised controlled trial that phacoemulsification gives a better visual outcome than extracapsular extraction with sutures. However, this trial was conducted in a developed country specialised hospital setting and extrapolation to other settings must be made with caution. This review also found evidence that extracapsular cataract extraction with a posterior chamber lens implant provides better visual outcome than intracapsular extraction with aphakic glasses. This finding is also based on the results of a single trial. The long term effects of posterior capsular opacification need to be assessed in larger populations. The data in the review suggest that intracapsular extraction with an anterior chamber lens implant is an effective alternative to intracapsular extraction with aphakic glasses, with similar safety. Further data from developing regions are needed to compare all aspects of intraocular lens surgery with the three main surgical procedures - intracapsular extraction with an anterior chamber lens, extracapsular surgery with a posterior chamber lens with or without sutures.
白内障是全球失明的主要原因,在发展中国家占所有失明病例的40%至80%。由于年龄分布的变化和预期寿命的增加,预计因白内障致盲的人数将会上升。目前尚无经证实的预防白内障的干预措施,手术是唯一的治疗方式。
本综述的目的是比较不同手术干预措施治疗年龄相关性白内障的效果。
我们检索了Cochrane对照试验注册库——CENTRAL/CCTR(其中包含Cochrane眼科和视力组专业注册库,《Cochrane图书馆》2001年第3期)、MEDLINE(1966年至2001年8月)、EMBASE(1980年至2001年9月)、已识别试验的参考文献列表,并且我们联系了该领域的研究者和专家以获取已发表和未发表试验的详细信息。
我们纳入了评估年龄相关性白内障患者手术治疗的随机对照试验。
两名综述作者独立提取数据,分歧通过讨论解决。在评估研究间的异质性后,酌情汇总相对风险、比值比和加权均数差。由于每个比较中的试验数量较少,我们使用了固定效应模型。
我们识别出6项试验,共随机分配了7828人。在英国进行的一项试验中,超声乳化术的视力结果优于囊外手术,且每次手术的平均费用相似。囊外摘除联合后房型人工晶状体植入术以及囊内摘除术(无论有无前房型人工晶状体植入)在术后12至24个月时的视力结果尚可接受。在南亚的3项大型试验中,最佳矫正视力低于6/60的比例在0.5%至4%之间。与由两名外科医生进行的单中心研究相比,在一项有19名外科医生参与的多中心研究中观察到较差结果的发生率更高。
本综述提供了一项随机对照试验的证据,表明超声乳化术的视力结果优于有缝线的囊外摘除术。然而,该试验是在发达国家的专科医院环境中进行的,外推至其他环境时必须谨慎。本综述还发现有证据表明,囊外白内障摘除联合后房型人工晶状体植入术的视力结果优于囊内摘除联合无晶状体眼镜。这一发现同样基于一项试验的结果。需要在更大规模人群中评估后囊膜混浊的长期影响。综述中的数据表明,前房型人工晶状体植入的囊内摘除术是囊内摘除联合无晶状体眼镜的有效替代方法,安全性相似。需要来自发展中地区的更多数据,以比较人工晶状体手术与三种主要手术方式(前房型人工晶状体植入的囊内摘除术、有或无缝线的后房型人工晶状体植入的囊外手术)各方面的情况。